We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
The OxPAQ is now validated for use in Chronic obstructive pulmonary disease (COPD), Aneurysmal subarachnoid haemorrhage (AHS) and Valvular heart disease.
Clinical Outcomes will be promoting some new additions to their portfolio of diabetes outcome measures at ATTD in Berlin, Germany, 20th -23rd February!
The Oxford Cognitive Screen, a stroke-specific screening test, is now available in Danish and an alternative to the MoCA.
In addition to the original Ox-PAQ, an acute version is now available which asks participants to recall their experiences during a much shorter time period of 1 week, rather than 4.
The Clinical Outcome team will be attending the first national ReQoL in Practice event in Sheffield, UK on the 29th November 2018.
With over 10 million people currently living with arthritis, Versus Arthritis (formerly Arthritis Research UK) pushes to defy the disease!
Oxford University Innovation's Clinical Outcome team will be attending the ISOQOL annual conference in Dublin, Ireland from the 24th - 27th October 2018.
Health Outcomes Insights helps healthcare agencies and pharmaceutical companies across a range of conditions including diabetes, get targeted answers to patient behaviour.
The Dutch (for Netherlands) translations of the ReQoL-10 and ReQoL-20 are now available!
Dr David Churchman to represent Clinical Outcomes team at the ISPOR Regional Meeting 2018 conference in Dubai.
